The Physiopathology of Avascular Necrosis of The Femoral Head - An Update
The Physiopathology of Avascular Necrosis of The Femoral Head - An Update
Injury
j o u r n a l h o m e p a g e : w w w. e l s e v i e r . c o m / l o c at e / I n j u r y
K E Y W O R D S A B S T R A C T
Bone necrosis The physiopathology of the femoral head bone necrosis is similar for children and for adults. The disease is
Avascular necrosis characterized by apoptosis of bone cells – bone marrow and bone forming cells-resulting in head collapse with a
Femoral head subsequent lesion of the overlying cartilage, and therefore flattening of the rounded surface shape of the head
Hip Fracture articulating with the acetabulum, provoking, eventually, secondary osteoarthritis. When the disease becomes
Cartilage disruption clinically evident already destructive phenomena have occurred and collapse will eventually ensue. In children,
Growth cartilage
because epiphyseal cartilage has growth capabilities, lost epiphyseal height can be recovered, however in adults
Perthes’ Disease
collapse is irreversible. In this paper the physiopathology of this disease is examined as well as its implication for
Genomics
treatment. Prevention by genetic studies is discussed.
© 2016 Elsevier Ltd. All rights reserved.
Avascular necrosis of the femoral head (ANFH) is not an uncommon Bone necrosis can be grouped according to its etiology in traumatic
disease characterized by apoptosis of bone cells – bone marrow, bone and non-traumatic cases, and also within these two groups, as
forming, and bone destroying cells-resulting in bone collapse with a pediatric or adult.
subsequent involvement of the overlying cartilage, provoking flatten- Many diseases, medicaments, and conditions are classified under
ing of the head surface with, eventually, development of secondary non-traumatic cases, as a complication of the original disease.
osteoarthritis [1–10]. In children, since most of the head cartilage has Traumatic cases are usually the result of a femoral neck fracture, and
growth properties – the so called epiphyseal cartilage-restoration of although the most common denomination for atraumatic ANFH has
head height and shape is possible and arthritis avoidance may be a been idiopathic, a metabolic disorder background is the most common
fact. The younger the child is the greater the capacity of growth and, keystone in every patient. The hepatic metabolism is usually altered
consequently the regeneration potential [11–14]. either by a primary syndrome, by alcohol intake or by the adminis-
The denomination “avascular” is very peculiar as the femoral tration of steroid medication for an immunogenic or autoimmune
head blood supplying vessels do not disappear; rather they suffer a disease.
pathological process which results in blood flow interruption. Alcohol is the most common etiology in adults; its intake is dose-
Although the nature of ANFH is basically defined upon the death of dependent being demonstrated that the relative risk of the disease is
cells, in the adult as well as in children, the diagnosis is normally made 3.3 if the intake is over 400 ml per week, 9.8 if the intake increases to 1
by images obtained through a non-invasive method, either with x-rays liter and up to 17.9 if more than this amount per week is consumed
or magnetic resonance (MRI). Therefore, what usually characterizes [15]. What alcohol disturbs is phospholipid and cytokines metabolism
the disease is the augmentation of bone density under x-rays, with a [16] but the final mechanism of how the blood supply interrupts and
subsequent disturbance of the femoral head shape in a limping patient the bone cells of the femoral head die is unknown [17]. That is why
with groin, thigh or even knee pain. Since the disease is usually silent patients developing antiphospholipid antibodies have threefold higher
for an undetermined time, former physiopathological events are risk of presenting an ANFH than control population as well as some
ignored by the time the clinician receives the patient. other metabolic diseases such as Gaucher’s disease [18].
Other disorders such as sickle cell hemoglobinopathies, mainly
homozygous sickle cell disease, present bone necrosis as a complica-
* Corresponding author at: Department of Orthopaedic Surgery and Traumatology, Hospital
tion. It has been estimated that after 35 years of the disease onset, 50%
Costa del Sol, University of Malaga, Autovía A-7. Km 187. 29603 Marbella (Malaga). Spain.
Tel: +34 951976224; Fax: +34 952823219. of the patients have developed bone necrosis [19]. Haematopoietic cell
E-mail address: [email protected] (E. Guerado). transplantation also can provoke bone necrosis which might be based
Ischemia phase
Fig. 5. The same specimen. Vascularization penetrating through the lateral part of
Fig. 3. The same specimen. Scintigraphy with decreased uptake on the left hip. the epiphyseal cartilage substituting the subchondral compact bone. Rhinelander
Posteroanterior image. technique.
Guerado and Caso / Injury, Int. J. Care Injured 47S6 (2016) S16–S26 S19
Fig. 9. The former case. A coxa magna with subluxation can be seen. In lateral projec-
tion (hip abduction and lateral rotation) centering of the head is evident.
Fig. 6. The same specimen and preparation. Vascularization underlying the epiphys-
eal cartilage substituting the subchondral compact bone.
Fig. 10. The former case. The right femoral head is well covered by the acetabulum
Fig. 7. Femoral head of an 11 week old rabbit treated with oxytetracyline. Femoral after Dega acetabular osteotomy. Anteroposterior x-ray projection.
head epiphysis height restitution thanks to cartilage proliferation. Still the vascular-
ization penetrating through the lateral part of the epiphyseal cartilage, substituting
the subchondral compact bone, can be seen.
Fig. 8. Right hip Legg-Calve-Perthes’ disease in a 7 year old male child. A coxa magna
with subluxation can be seen. Anteroposterior x-ray projection. Fig. 11. The former case. Lateral projection.
S20 Guerado and Caso / Injury, Int. J. Care Injured 47S6 (2016) S16–S26
Fig. 12. Femoral head of an 11 week old rabbit treated with oxytetracyline.
Substitution of the compact subchondral bone is evident. Fig. 15. Femoral head of a 59 year old man diagnosed of ANFH. A subchondral frac-
ture can be easily seen. A rod is drawn in order to show the difficulties of drilling
and buttressing the hole affected volume of bone necrosis.
Fig. 16. Femoral head of an 11 week old rabbit treated with oxytetracyline. Lateral
Fig. 13. The same specimen. Cancellous dead bone trabeculi with osteogenetic prolif- flattening of the femoral head after bone collapse.
eration in a formerly necrotic femoral head.
Fig. 17. The same specimen. This lateral epiphyseal growth cartilage surface shows Fig. 19. Bone necrosis of the femoral head of a 57 year old patient, who had under-
chondroblasts proliferation in order to repair femoral head height loss. See Figure 7. gone a varization osteotomy for the treatment of avascular necrosis of the femoral
head. The articular cartilage has a step off defect overlying the necrotic area.
Since it looks worldwide accepted that once collapse occurs the clearer the etiopathogenesis of LCPD and its relation with the
progression to osteoarthritis cannot be stopped [7–9], core decom- “intravascular theory”.
pression of the head has been claimed to be effective in incipient bone Other studies have pointed that there is a constitutional problem in
necrosis before the articular cartilage is affected and the head flattens children developing LCPD and the cause of the epiphyseal ischemia
(Figure 15). Nonetheless according to basic science studies, by drilling is not intravascular, but extravascular. The observation of concurrent
into the necrotic zone regenerative phase would accelerate and bone diseases related to mesenchyme growth has been, since long, the base
collapse could occur even earlier. Therefore, although several patients for that hypothesis [57,58,106,107]. Congenital genitourinary and
may feel some pain relief after core decompression, as pathological ilioinguinal hernia had been studied during the eighties, and recently
high venous pressure is drastically diminished, no differences in terms shown after studying large databases [108]. These studies have also
of disease outcome have been found between core decompression and shown regional distribution of the disease even within the same
abstention, and collapse will occur without delay whether or not core country [107]. However, declining incidence of LCPD suggests that
decompression is performed. So far, no well-designed study has found environment may also be determinant for the disease onset [108].
differences in relation to collapse between femoral head undergoing The “extravascular –constitutional-theory” based on an epiphyseal
core decompression and abstention [88,89]. cartilage collagen alteration and consequently a disruption of the
Proximal femur osteotomies have also been used for the treatment vascular canals piercing the cartilage, has also been explained by
of the ANFH in the adult, but the aim of it is to change the necrotic area genetic aetiology. Type II collagenopathies, including LCPD and ANFH
from loading, therefore it is assumed that collapse has or is going to would consist of the replacement of the triple helical (Gly-X-Y) of the
ensue (Figure 19). Varization osteotomy alone or in combination with extracellular matrix by other amino acids. Since type II collagen is
derotation is aimed to release the pressure from the necrotic area, by encoded by the COL2A1 gene and contains N- and C-terminal regions,
loading a healthy part of the head instead of the affected one. mutation of COL2A1 would result in a collagenopathy [109,110] and
Nevertheless, so far no methodological well designed study has been therefore an alteration of the biomechanical properties of the vessels-
made on the effectiveness of femoral osteotomy for the treatment of containing epiphyseal cartilage. Medical literature reports on abundant
ANFH and this treatment, very popular among orthopaedic surgeons in private mutations in COL2A1 associated with diverse clinical pheno-
the eighties, is currently not very much in use as anatomy of the types of chondrogenesis alteration [111]. Therefore, DNA mutation
proximal femur is very much altered, compromising the technique of a analysis might be valuable for identifying other at-risk family members
secondary joint replacement. Variables such as age, necrotic volume, when a diagnosis of LCPD has been made [111,112].
osteotomy types and others make osteotomies outcome very uncer- In a very interesting study, Gly1170Ser mutation of COL2A1has also
tain, and nowadays only joint replacement may guarantee – provided been found in several families with an inherited disease of the hip
there are no complications- a satisfactory result. Single or combined joint, including ANFH and LCPD. Histological studies showed that the
proximal femoral or acetabular osteotomies are of current use in LCPD hierarchical structure of the transmuted cartilage and the imbedded
[90,91] with very long term good results [14,92] (Figure 10 and 11). chondrocytes were significantly abnormal. The expression and
Some others attempt to help regeneration by introducing either distribution of type II collagen was not uniform in sections of the
artificial stems [93] (Figure 15), growth factors or MSCs have not shown cartilage. Studies under electron microscopy also showed clearly
to improve abstention [74]. Old techniques are reborn with some abnormal chondrocytes as well as an abnormal arrangement of collagen
modifications [94], and mixtures of therapies have also been published. fibers in the transmuted chondral matrix. Likewise, the predicted
Medline bibliography search in current data bases combining different stability of type II collagen greatly decreased with the substitution of
therapies obtains an overwhelming amount of references nearly all of serine by glycine. The authors concluded that Gly1170Ser mutation of
them with “promising results”. Therefore, disease prevention programs COL2A1 can cause significant structural alterations in articular cartilage,
are essentials as once the disease has triggered, no reliable therapy is which are responsible for the new type II collagenopathy [113].
available. Studies on this alteration have also been carried out in dogs [114],
and also nearly thirty years ago we had created an animal experimental
Genetics determination as a future prevention tool of the ANFH model of LCPD inducing a chondrogenesis alteration during growth by
the administration of high doses of oxytetracycline – an antibiotic
Genetics is a very useful tool in order to know susceptibility of interfering with proteins’ synthesis- [38]. We also observed, years later,
people to suffering from ANFH. Prevention programs could be that patients having LCPD during childhood had also developed some
instituted for anticipating risks of diseases, benefits and risks of others chondrogenesis-related alterations, clinically silent, during
therapies and habits in relation to ANFH. their growth period [115].
Differential expression of genes encoding for proteins involved in A group of authors claim a relation between the appearance of
thrombus formation in the microvasculature, coagulation pathway, LCPD and genetic protheathesis but do not support either theory, being
ischemia, angiogenesis, apoptosis, lipid biosynthesis and bone remod- intra or extravascular; they just discuss on that correlation [116].
elling have been suggested to be responsible for the progression to Although some authors found evidence of family proclivity to suffer
the end stage of ANFH in adults [95]. In children the hypothesis that LCPD, some others failed in founding a genetic component, even
LCPD is caused by intravascular thrombosis causing epiphyseal between monozygotic twin pairs [117]. Likewise, it has been found that
ischemia, has been empirically studied [96–98]. However, although children heterozygous for IL-6 G-174C/G-597A polymorphisms pre-
according to coagulation parameters the role of thrombophilia can sented a lower probability of presenting LCPD than those being
develop the disease [71,99–101], no effect has been demonstrated on homozygote [118].
the severity of it [98]. By PCR-RFLP analysis, proapoptotic Bax factor and Bax/Bcl-2
The “intravascular aetiology” and its relation with genetics has also ratio have shown overexpression also in LCPD patients [119]. Children
been discussed for LCPD. Some authors have found that a factor V with heterozygous IL-6 G-174C/g-597A polymorphism have lower
Leiden mutation is very much related to this disease, and that by risk of developing LCPD [118]. But no overall association between
screening this mutation, children under risk could be identified in MTHER gene polymorphisms and ANFH has been suggested in LCPD
advance [12,22–29]. Some other authors have failed to find that patients [120].
association [102,103], nor even any coagulopathy associated to LCPD Whether LCPD is related or triggered by either intra or extravascular
[104]. Alterations of thrombogenesis such as a beta fibrinogen gene G- causes is not well known as one of the problem starts since the own
455-A polymorphism have related LCPD with passive smoke exposure definition of the disease. Many concurrent diseases have been
[105]. Therefore, genetics have not found definitive hints making described to be associated with LCPD, based just on the simple
Guerado and Caso / Injury, Int. J. Care Injured 47S6 (2016) S16–S26 S23
observation of x-rays resembling the usual images for LCPD [21,103, questions about reporting incidental findings (IF) derived from WES
121–144]. analysis, such as identifying medically relevant mutations in genes
Recent results from genome-wide (GW) transcriptomics on unrelated to the diagnostic question and sex chromosome abnormal-
immature articular cartilage of piglets following osteonecrosis of ities that need to be addressed.
femoral head (ANFH) have shown upregulation of several hundred of
protein-coding genes compared to the normal controls, reinforcing the Conflict of interest
role of the immature articular cartilage following ANFH [145]. The
encoded proteins upregulated along the phases of ANFH are involved No benefits in any form have been received or will be received from
in different molecular pathways, including HIF-1, PI3K-Akt, MAPK, a commercial party related directly or indirectly to the subject of this
focal adhesion and TNF-a signalling pathway. These pathways article.
participate in oxidoreductive, cell-survival, angiogenic and inflamma-
tory responses, throughout secretory and chemokine signalling Acknowledgments
proteins. The differential gene expression of relevant genes (HIF-1A,
The researches illustrating this paper were carried out during the
VEGFA, IL-6, IL6R, IL-8, CCL2, FGF2, TGFB2, MMP1, MMP3, ITGA5, FN
middle of the eighties at the Nuffield Orthopaedic Centre (NOC) while
and Col6A1) was confirmed by quantitative reverse-transcriptase
one of the authors (EG) stayed in Oxford; also during the late eighties
polymerase change reaction (qRTPCR) analysis.
studies were performed at the University Autonoma of Madrid by the
Genotyping studies on adult ANFH have suggested an association of
same author, and along the last twenty years, the Ministry of Health of
gene-encoding protein polymorphisms with ANFH. A recent meta-
the Spanish Government, together with the regional government of
analysis [146] has found increased risk of ANFH after focusing the
Andalusia, supported the University of Malaga, and the Hospital Costa
studies on VEGF, eNOS and ABCB1. Genetic variations in angiogenesis
del Sol with several generous grants. Thanks are given to these
and hypoxia-related genes may be considered as a susceptibility factor
Institutions.
for the development of ANFH since the IGFBP3 gene polymorphism
was significantly associated with a higher risk of ANFH [147]. A recent
systematic review on VEGF protein, highly expressed around the References
necrotic area of the ANFH, suggests a significant association of VEGF
[1] Phemister DB. Repair of bone in the presence of aseptic necrosis resulting from fracture
gene −634G/C polymorphism with ANFH [148]. Also, TNF-ft gene transplantation and vascular disorders. J Bone Jt Surg 1930;12:769–87.
polymorphisms detected by PCR-RDB were suggested as a risk for [2] Catto MA. Histological study of avascular necrosis of the femoral head after transcervical
steroid-induced ANFH and in patient with hypoxic state [149]. Reduced fracture. J Bone Jt Surg Br 1965;47:749–76.
eNOS activity as a consequence of a gene polymorphisms in intron 4 [3] Catto M. Pathology of aseptic bone necrosis. In: Davidson JK, editor. Aseptic necrosis of
bone. Amsterdam: Excerpta Medica; 1976.
(27-base pair repeat) and in exon 7 (G894T) has been detected by PCR-
[4] Catto M. The histological appearances of late segmental collapse of the femoral head
RLP in non-traumatic ANFH [112]. In glucocorticoid-induced ANFH after transcervical fracture. J Bone Joint Surg Br 1965;47:777–91.
significant reduced risk has been detected for ABCB1 gene polymorph- [5] Davidson JK, Harrison JA, Jacobs P, Hilditch TE, Catto M, Hendry WT. The significance
isms [150,151], ACE polymorphisms [147] and MDR1 gene [152]. of bone islands, cystic areas and sclerotic areas in dysbaric osteonecrosis. Clin Radiol
1977;28:381–93.
Differences in the haplotype of ApoA5 gene in Chinese population have
[6] Kenzora JE, Steele RE, Yosipovitch ZH, Glimcher MJ. Experimental osteonecrosis of the
been associated with increased or decreased risk for ANFH [153]. femoral head in adult rabbits. Clin Orthop Relat Res 1978;130:8–46.
Studies by PCR-RFL on Caucasian population found that hypofibrino- [7] Glimcher MJ, Kenzora JE. The biology of osteonecrosis of the human femoral head and its
lysis associated with Plat TAP25 gene polymorphism is a risk factor of clinical implications: 1. Tissue biology. Clin Orthop Relat Res 1979;138:284–309.
[8] Glimcher MJ, Kenzora JE. The biology of osteonecrosis of the human femoral head and its
ANFH [154]. A metaanalysis on plaminogen activator inhibitor (PAI-1)
clinical implications: II. The pathological changes in the femoral head as an organ and in
showed an association of the 4 G/5 G and 4G4G polymorphisms with the hip joint. Clin Orthop Relat Res 1979;139:283–312.
risk of ANFH [155]. [9] Glimcher MJ, Kenzora JE. The biology of osteonecrosis of the human femoral head and its
The fact that sets of encoded-protein genes were up-regulated clinical implications. III. Discussion of the etiology and genesis of the pathological
along the different phases of the ANFH process may be of great value to sequelae; commments on treatment. Clin Orthop Relat Res 1979;140:273–312.
[10] Jacqueline F, Rutishauser E. Idiopathic necrosis of the femoral head (anatomopatholo-
look for molecular biomarkers for clinical practice. For instance, the gical study). In: Zinn WU, editor. Idiopathic oschaemic necrosis of the femoral head in
383 genes up-regulated at 24 hours after ANFH induction, could be adults. Stuttgart: Thieme Publ., 1971; pp. 34–48.
useful for detection of the acute ischemic-hypoxic injury phase. In the [11] Guerado E, Benavente M, Queipo de Llano E. Resultados del tratamiento en el síndrome
avascular necrosis phase (2 weeks after ANFH induction), 122 up- de Perthes (I). Contenimiento versus no contenimiento (Spanish). Rev Ortop Traum
1989;33IB:481–5.
regulated genes were related to angiogenesis, inflammation and
[12] Guerado E, Benavente M, Queipo de Llano E. Resultados del tratamiento en el síndrome
matrix remodelling, making evident the role of immature articular de Perthes (II). Tratamiento con Yesos Abductores (broomstick) versus osteotomía de
cartilage into matrix formation, growth factor binding and cell varización derrotación femoral (Spanish). Rev Ortop Traum 1989;33IB:486–9.
signalling mechanisms. Moreover, at the early repair phase (4 weeks [13] Schoenecker PL, Stone JW, Capelli AM. Legg-Perthes disease in children under 6 years
old. Orthop Rev 1993;22:201–8.
after ANFH induction) the predominant up-regulated genes were
[14] Aydin BK, Sofu H, Konya MN, Er T, Sahin V. Clinical and radiographic outcomes
those involved in chemokine/receptor/matrix binding and cytokine after femoral varus derotation osteotomy for Legg-Calvé-Perthes disease at 25 years
activity [145]. follow-up: what are the determinants of outcome in the long term? Hip Int
In the postgenomic era, the precision medicine emerges as a 2016;26:301–6.
[15] Matsuo K, Hirohata T, Sugioka Y, Ikeda M, Fukuda A. Influence of alcohol intake, cigarette
medical model using molecular profiling technologies to interrogate
smoking, and occupational status on idiopathic osteonecrosis of the femoral head. Clin
clinical samples for a variety of molecules, including DNA, RNA, Orthop Relat Res 1988;234:115–23.
proteins, and metabolites. Next Generation sequencing technologies [16] McClain CJ, Song Z, Barve SS, Hill DB, Deaciuc I. Recent advances in alcoholic liver disease.
have increased gene discovery, understanding the causes of single- IV. Dysregulated cytokine metabolism in alcoholic liver disease. Am J Physiol
gene disorders among patients with suspected, but previously Gastrointest Liver Physiol 2004;287:G497–502.
[17] Lucey MR, Mathurin P, Morgan TR. Alcoholic hepatitis. N Engl J Med 2009;360:2758–69.
undiagnosed, genetic disorders. Whole-exome sequencing (WES) [18] Goldblatt J, Sacks S, Beighton P. The orthopedic aspects of Gaucher disease. Clin Orthop
using next generation sequencing technologies brings up the possi- Relat Res 1978;137:208–14.
bility to determine the exomic variation profile detected in ANFH. [19] Jones LC, Mont MA. Ostesonecrosis (avascular necrosis of bone). UpToDate. Wolters
Particular limitations in WES are the gaps in coverage of the exome, Kluwer. December 2015. http://www.uptodate.com/contents/osteonecrosis-avascular-
necrosis-of-bone (data last Access 8 October 2016).
finding the causal mutation among the enormous background of
[20] Tauchmanovà L, De Rosa G, Serio B, Fazioli F, Mainolfi C, Lombardi G, et al. Avascular
individual variability in a small number of simples, and difficulty necrosis in long-term survivors after allogeneic or autologous stem cell transplantation:
interpreting variants are still big challenges. There are also ethical a single center experience and a review. Cancer 2003;97:2453–61.
S24 Guerado and Caso / Injury, Int. J. Care Injured 47S6 (2016) S16–S26
[21] Gruppo R, Glueck CJ, Wall E, Roy D, Wang P. Legg-Perthes disease in three siblings, two [53] Catterall A, Pringle J, Byers PD, Fulford GE, Kemp HB, Dolman CL, et al. A review of the
heterozygous and one homozygous for the factor V Leiden mutation. J Pediatr morphology of Perthes’ disease. J Bone Joint Surg Br 1982;64:269–75.
1998;132:885–8. [54] Burch PR, Nevelos AB. Perthes’ disease: a new genetic hypothesis. Med hypothesis
[22] Hayek S, Kenet G, Lubetsky A, Rosenberg N, Gitel S, Wientroub S. Does thrombophilia 1979;5:513–28.
play an aetiological role in Legg-Calvé-Perthes disease? J Bone Joint Surg Br [55] Gray IM, Lowry RB, Renwick DH. Incidence and genetics of Legg-Perthes disease
1999;81:686–90. (osteochondritis deformans) in British Columbia: evidence of polygenic determination.
[23] Arruda VR, Belangero WD, Ozelo MC, Oliveira GB, Pagnano RG, Volpon JB, et al. Inherited J Med Genet 1972;9:197–202.
risk factors for thrombophilia among children with Legg-Calvé-Perthes disease. J Pediatr [56] Harper PS, Brotherton BJ, Cochlin D. Genetic risks in Perthes’ disease. Clin Genet
Orthop 1999;19:84–7. 1976;10:178–82.
[24] Balasa VV, Gruppo RA, Glueck CJ, Wang P, Roy DR, Wall EJ, et al. Legg-Calve-Perthes [57] Hall DJ. Genetic aspects of Perthes’ disease. A critical review. Clin Orthop Relat Res
disease and thrombophilia. J Bone Joint Surg Am 2004;86:2642–7. 1986;209:100–14.
[25] Szepesi K, Pósán E, Hársfalvi J, Ajzner E, Szücs G, Gáspár L, et al. The most severe forms of [58] Hall DJ, Harrison MH, Burwell RG. Congenital abnormalities and Perthes’ disease.
Perthes’ disease associated with the homozygous Factor V Leiden mutation. J Bone Joint Clinical evidence that children with Perthes’ disease may have a major congenital defect.
Surg Br 2004;86:426–9. J Bone Joint Surg Br 1979;61:18–25.
[26] Glueck CJ, Crawford A, Roy D, Freiberg R, Glueck H, Stroop D. Association of [59] Burwell RG, Dangerfield PH, Hall DJ, Vernon CL, Harrison MH. Perthes’ disease. An
antithrombotic factor deficiencies and hypofibrinolysis with Legg-Perthes disease. anthropometric study revealing impaired and disproportionate growth. J Bone Joint
J Bone Joint Surg Am 1996;78:3–13. Surg Br 1978;60-B:461–77.
[27] Kenet G, Ezra E, Wientroub S, Steinberg DM, Rosenberg N, Waldman D, et al. Perthes’ [60] Harrison MH, Burwell RG. Perthes’ disease: a concept of pathogenesis. Clin Orthop Relat
disease and the search for genetic associations: collagen mutations, Gaucher’s disease Res 1981;156:115–27.
and thrombophilia. J Bone Joint Surg Br 2008;90:1507–11. [61] Hall AJ, Barker DJ, Dangerfield PH, Osmond C, Taylor JF. Small feet and Perthes’ disease.
[28] Vosmaer A, Pereira RR, Koenderman JS, Rosendaal FR, Cannegieter SC. Coagulation A survey in Liverpool. J Bone Joint Surg Br 1988;70:611–3.
abnormalities in Legg-Calvé-Perthes disease. J Bone Joint Surg Am 2010;92:121–8. [62] Douglas G, Rang M. The Role of trauma in the pathogenesis of the osteochondroses. Clin
[29] Woratanarat P, Thaveeratitharm C, Woratanarat T, Angsanuntsukh C, Attia J, Orthop Relat Res 1981;158:28–32.
Thakkinstian A. Meta-analysis of hypercoagulability genetic polymorphisms in [63] Batory I. Opinions on and comparative observations about the etiology of Perthes’
Perthes disease. J Orthop Res 2014;32:1–7. disease. Arch Orthop Trauma Surg 1982;100:151–62.
[30] Zizic TM, Marcoux C, Hungerford DS, Dansereau JV, Stevens MB. Corticosteroid therapy [64] Paterson D, Savage JP. The nuclide bone scan in the diagnosis of Perthes’ disease. Clin
associated with ischemic necrosis of bone in systemic lupus erythematosus. Am J Med Orthop Relat Res 1986;209:23–9.
1985;79:596–604. [65] Alberts KA, Dahlborn M, Glas JE, Hindmarsh J, Ringertz H. Radionuclide scintigraphy of
[31] Abeles M, Urman JD, Rothfield NF. Aseptic necrosis of bone in systemic lupus femoral head specimens removed at arthroplasty for failed femoral neck fractures. Clin
erythematosus. Relationship to corticosteroid therapy. Arch Intern Med 1978;138: Orthop Relat Res 1986;205:222–9.
750–4. [66] Van Campenhout A, Moens P, Fabry G. Reliability of serial bone scintigraphy
[32] Mont MA, Glueck CJ, Pacheco IH, Wang P, Hungerford DS, Petri M. Risk factors for classification according to Conway in Legg-Calvé-Perthes disease. Acta Orthop Belg
osteonecrosis in systemic lupus erythematosus. J Rheumatol 1997;24:654–62. 2007;73:196–9.
[33] Asherson RA, Lioté F, Page B, Meyer O, Buchanan N, Khamashta MA, et al. Avascular [67] Tsao AK, Dias LS, Conway JJ, Straka P. The prognostic value and significance of serial bone
necrosis of bone and antiphospholipid antibodies in systemic lupus erythematosus. scintigraphy in Legg-Calvé-Perthes disease. J Pediatr Orthop 1997;17:230–9.
J Rheumatol 1993;20:284–8. [68] de Sanctis N, Rondinella F. Prognostic evaluation of Legg-Calvé-Perthes disease by MRI.
[34] Mok MY, Farewell VT, Isenberg DA. Risk factors for avascular necrosis of bone in patients Part II: pathomorphogenesis and new classification. J Pediatr Orthop 2000;20:463–70.
with systemic lupus erythematosus: is there a role for antiphospholipid antibodies? [69] Crisan M, Yap S, Casteilla L, Chen CW, Corselli M, Park TS, et al. A perivascular origin for
Ann Rheum Dis 2000;59:462–7. mesenchymal stem cells in multiple human organs. Cell Stem Cell 2008;3:301–13.
[35] Miller KD, Masur H, Jones EC, Joe GO, Rick ME, Kelly GG, et al. High prevalence of [70] Da Silva Meirelles L, Caplan AI, Nardi NB. In search of the in vivo identity of mesenchymal
osteonecrosis of the femoral head in HIV-infected adults. Ann Intern Med 2002; stem cells. Stem Cells 2008;26:2287–99.
137:17–25. [71] Glueck CJ, Freiberg R, Tracy T, Stroop D, Wang P. Thrombophilia and hypofibrinolysis:
[36] Martin K, Lawson-Ayayi S, Miremont-Salamé G, Blaizeau MJ, Balestre E, Lacoste D, et al. pathophysiologies of osteonecrosis. Clin Orthop Relat Res 1997;334:43–56.
Symptomatic bone disorders in HIV-infected patients: incidence in the Aquitaine cohort [72] Feng Y, Yang SH, Xiao BJ, Xu WH, Ye SN, Xia T, et al. Decreased in the number and function
(1999-2002). HIV Med 2004;5:421–6. of circulation endothelial progenitor cells in patients with avascular necrosis of the
[37] Kaushik AP, Das A, Cui Q. Osteonecrosis of the femoral head: an update in year 2012. femoral head. Bone 2010;46:32–40.
World J Orthop 2012;3:49–57. [73] Séguin C, Kassis J, Busque L, Bestawros A, Theodoropoulos J, Alonso ML, et al. Non-
[38] Guerado E. Studies on the pathogenesis of Legg-Calvé-Perthes’ Syndrome. An traumatic necrosis of bone (osteonecrosis) is associated with endothelial cell activation
experimental Model (Spanish, abstract in English). Doctoral thesis. Madrid, University but not thrombophilia. Rheumatology (Oxford) 2008;47:1151–5.
Autonoma, 1988. Available at https://repositorio.uam.es/handle/10486/8756 (last [74] Song HJ, Lan BS, Cheng B, Zhang KF, Yan HW, Wang WZ, et al. Peripheral blood stem cell
accessed 25 September 2016). transplantation for ischemic femoral head necrosis. Transplant Proc 2010;42:1862–4.
[39] Nishio A, Yakushiji K. Legg-Calvé-Perthes disease histology and treatment. Yonago Acta [75] Trueta J. The normal vascular supply anatomy of the femoral head during growth. J Bone
Medica 1962;6:1–4. Jt Surg Br 1957;39:358–94.
[40] Suramo I, Puranen J, Heikkinen E, Vuorinen P. Disturbed patterns of venous drainage of [76] Wertheimer LG, Lopes S de L. Arterial supply of the femoral head. A combined
the femoral neck in Perthes diease. J Bone Jt Surg Br 1974;56:448–53. angiographic and histological study. J Bone Joint Surg Am 1971;53:545–56.
[41] Green NE, Griffin PP. Intra-osseous venous pressure in Legg-Perthes’ disease. J Bone Jt [77] Ogden JA. Changing patterns of proximal femoral vascularity. J Bone Joint Surg Am
Surg Am 1982;64:666–71. 1974;56:941–50.
[42] Iwasaki K, Suzuki R, Okazaki T, Ikeda S, Inoue Y, Shimauchi R. The haemodynamics of [78] Chung SMK. The arterial supply of the developing proximal end of the human femur.
Perthes’ disease. Int Orthop 1982;6:141–8. J Bone Jt Surg Am 1976;58:961–70.
[43] Pires de Camargo FP, Maciel de Godoy R, Tovo R. Angiography in Perthes’ disease. Clin [79] Howell DW, Duran CL, Tsai SP, Bondos SE, Bayless KJ. Functionalization of ultrabithorax
Orthop Relat Res 1984;191:216–20. materials with vascular endothelial growth factor enhances angiogenic activity.
[44] Wingstrand H. Intracapsular pressure in transient synovitis of the hip. Acta Orthop Biomacromolecules 2016;17:3558–69.
Scand 1985;56:204–10. [80] Zhang HX, Zhang XP, Xiao GY, Hou Y, Cheng L, Si M, et al. In vitro and in vivo evaluation of
[45] Kleinman RG, Bleck EE. Increased blood viscosity in patients with Legg-Perthes’ disease: calcium phosphate composite scaffolds containing BMP-VEGF loaded PLGA micro-
a preliminary report. J Pediatr Orthop 1981;1:131–6. spheres for the treatment of avascular necrosis of the femoral head. Mater Sci Eng C
[46] Ponseti IV, Shepard RS. Lesions of the skeleton and of other mesodermal Mater Biol Appl 2016;60:298–307.
tissues in rats fed sewwt-pea (Lathyrus odoratus) seeds. J Bone Jt Surg Am 1954;36: [81] Muirhead-Allwood W, Catterall A. The treatment of Perthes’ disease. The results of a trial
1031–58. of management. J Bone Joint Surg Br 1982;64:282–5.
[47] Duthie RB, Houghton GR. Constitutional Aspects of Osteochondroses. Clin Orthop Relat [82] Ismail AM, Macnicol MF. Prognosis in Perthes’ disease: a comparison of radiological
Res 1981;158:19–27. predictors. J Bone Joint Surg Br 1998;80:310–4.
[48] Ippolito E. Legg-Calvé-Perthes’ (LCP) disease in the light of recent findings. Ital J Orthop [83] Kenzora JE, Glimcher MJ. Pathogenesis of idiopathic osteonecrosis: the ubiquitous
Traumatol 1982;8:77–92. crescent sign. Orthop Clin North Am 1985;16:681–96.
[49] Ponseti IV, Maynard JA, Weinstein SL, Ippoliti EG, Pous JG. Legg-Calvé-Perthes disease. [84] Atsumi T, Kuroki Y. Role of impairment of blood supply of the femoral head in the
Histichemical and ultraestructural observations of the epiphyseal cartilage and physis. pathogenesis of idiopathic osteonecrosis. Clin Orthop Relat Res 1992;277:22–30.
J Bone Jt Surg Am 1983;65:797–807. [85] Hauzeur JP, Perlmutter N, Appelboom T, Pasteels JL. Medullary impairment at early stage
[50] Peruggia L, Ippoliti E. Pathogenesis of Legg-Calvé-Perthes disease. Ital J Orthop of non-traumatic osteonecrosis of the femoral head. Rheumatol Int 1991;11:215–7.
Traumatol 1983;9:211–7. [86] Ohzono K, Saito M, Takaoka K, Ono K, Saito S, Nishina T, et al. Natural history of
[51] Nagasaka K. Histological study of eight cases of osteochondritis deformans coxae nontraumatic avascular necrosis of the femoral head. J Bone Joint Surg Br 1991;73:
juvenilis (Legg-Calvé-Perthes). Fukuoka Ikwadaigaku Zasshi 1930;23:108–54. 68–72.
[52] Catterall A, Pringle J, Byers PD, Fulford GE, Kemp HB. Perthes’ disease: is the epiphysial [87] Milgram JW. Reparative cartilaginous callus in subarticular osteonecrosis of bone. A
infarction complete? J Bone Joint Surg Br 1982;64:276–81. histopathological study of the femoral head. Clin Orthop Relat Res 1984;186:272–83.
Guerado and Caso / Injury, Int. J. Care Injured 47S6 (2016) S16–S26 S25
[88] Koo KH, Kim R, Ko GH, Song HR, Jeong ST, Cho SH, et al. Preventing collapse in early [119] Srzentić S, Nikčević G, Spasovski D, Baščarević Z, Živković Z, Terzic-Šupić Z, et al.
osteonecrosis of the femoral head. A randomised clinical trial of core decompression. Predictive genetic markers of coagulation, inflammation and apoptosis in Perthes
J Bone Joint Surg Br 1995;77:870–4. disease—Serbian experience. Eur J Pediatr 2015;174:1085–92.
[89] Mc Grory BJ, York SC, Iorio R, Macaulay W, Pelker RR, Parsley BS, et al. Current practices of [120] Chai W, Zhang Z, Ni M, Geng P, Lian Z, Zhang G, et al. Genetic association between
AAHKS members in the treatment of adult osteonecrosis of the femoral head. J Bone methylenetetrahydrofolate reductase gene polymorphism and risk of osteonecrosis of
Joint Surg Am 2007;89:1194–204. the femoral head. Biomed Res Int 2015;2015:196495.
[90] Kamegaya M, Morita M, Saisu T, Kakizaki J, Oikawa Y, Segawa Y. Single versus combined [121] Albright F. Changes simulating Legg-Perthes disease (Osteochondritis Deformans
procedures for severely involved Legg-Calvé-Perthes disease. J Pediatr Orthop 2016 Jul Juvenilis) due to juvenile myxedema. J Bone Joint Surg 1938;20:764–9.
20. [Epub ahead of print]. [122] Draznin SZ, Singer K. Legg-Perthes’ disease (Syndrome of many aetiologies) with
[91] Napiontek M, Pietrzak S. Double osteotomy in the surgical treatment of Perthes’ disease: clinical and roentgenographic findings in a case of Gaucher’ disease. Am J Roent
Dega’s transiliac osteotomy and subtrochanteric osteotomy. Ortop Traumatol Rehabil 1948;60:490–1.
2004;6:728–32. [123] Meyer S. Dysplasia epiphysealis Capitis femoris. Acta Orthop Scand 1964;34:183–97.
[92] Shohat N, Copeliovitch L, Smorgick Y, Atzmon R, Mirovsky Y, Shabshin N, et al. The long- [124] Boldero JL, Kemp FH. The early bone and joint changes in haemophilia and similar blood
term outcome after varus derotational osteotomy for Legg-Calvé-Perthes disease: a dyscrasias. Br J Radiol 1966;39:172–80.
mean follow-up of 42 years. J Bone Joint Surg Am 2016;98:1277–85. [125] Crawford AH. Legg-Calvé-Perthes’ disease. Disease coexistent with slipped capital
[93] Xiao D, Ye M, Li X, Yang L. Development of femoral head interior supporting device and femoral epiphysis. A case report. J Bone Joint Surg Am 1975;57:280–1.
3D finite element analysis of its application in the treatment of femoral head avascular [126] Matsoukas JA. Viral antibody titers to rubella in coxa plana of Perthes’ Disease. Perthes’
necrosis. Med Sci Monit 2015;21:1520–6. disease: is the late osseous residua of a minor prenatal rubella? Acta Orthop Scand
[94] Vaishya R, Agarwal AK, Gupta N, Vijay V. Sartorius muscle pedicle iliac bone graft for the 1975;46:957–62.
treatment of avascular necrosis of femur head. J Hip Preserv Surg 2016;3:215–22. [127] Bjerkreim I, Trygstad O. Necrosis of the capital epiphysis ocurring during human growth
[95] Pouya F, Kerachian MA. Avascular necrosis of the femoral head: are any genes involved? hormone therapy. Acta Orthop Scand 1976;47:189–92.
Arch Bone Jt Surg 2015;3:149–55. [128] Guillozet N. Perthes’ Disease after poliomyelitis. Recognition and management of
[96] Thomas DP, Morgan G, Tayton K. Perthes’ disease and the relevance of thrombophilia. aseptic capital femoral necrosis. Clin Pediatr (Phila.) 1981;20:19–23.
J Bone Joint Surg Br 1999;81:691–5. [129] Bowen JR, Schmidt T. Osteochondroma of the femoral neck in Perthes’ disease. J Pediatr
[97] Gallistl S, Reitinger T, Linhart W, Muntean W. The role of inherited thrombotic disorders Orthop 1983;3:28–30.
in the etiology of Legg-Calvé-Perthes disease. J Pediatr Orthop 1999;19:82–3. [130] Cope R, Beals RK, Bennet RM. The trichorhinophalangeal dysplasia syndrome: report of
[98] Moens P, Defoort K, Vancampenhout A, Peerlinck K, Fabry G. Thrombophilia and Legg- eight kindreds, with emphasis on hip complicactions, late presentations and premature
Calvé-Perthes disease: is it a causative factor and does it affect the severity of the osteoarthristis. J Ped Orthop 1986;6:133–8.
disease? Acta Orthop Belg 2007;73:612–7. [131] Griffiths HE, Vitherow FJ. Perthes’ disease and multiple epiphyseal dysplasia. Postgrad
[99] Hunt DM, Holmes Z, Pickering W, Cohen H. Association of antithrombotic factor Med J 1977;53:464–72.
deficiencies and hypofibrinolysis with Legg-Perthes disease. J Bone Joint Surg Am [132] Guerado E, Garces G. Necrosis de la cabeza femoral en la infancia consecutiva a
1998;80:604–6. enfermedad de células falciformes (Spanish). Rev Ortop Traum 1987;31-IB:579–82.
[100] Herndon WA. Association of antithrombotic factor deficiencies and hypofibrinolysis [133] Moss C, Robson BJ. Haemangiectatic hypotrophy associated with Perthes’ disease. Clin
with Legg-Perthes disease. J Bone Joint Surg Am 1997;79:1114–5. Exp Dermatol 1988;13:237–9.
[101] Kahle WK. Association of antithrombotic factor deficiencies and hypofibrinolysis with [134] Garrett C, Tripp JH. Unknown syndrome: mental retardation with postaxial polydactyly,
Legg-Perthes disease. J Bone Joint Surg Am 1997;79:1114–5. congenital absence of hair, severe seborrhoeic dermatitis, and Perthes’ disease of the
[102] López-Franco M, González-Morán G, De Lucas JC, Jr, Llamas P, de Velasco JF, hip. J Med Genet 1988;25:270–2.
Vivancos JC, et al. Legg-perthes disease and heritable thrombophilia. J Pediatr Orthop [135] Herring JA, Hotchkiss BL. Legg-Perthes disease versus multiple epiphyseal dysplasia.
2005;25:456–9. J Pediatr Orthop 1987;7:341–3.
[103] Kenet G, Hayek S, Mor M, Lubetsky A, Miller L, Rosenberg N, et al. The 1226G (N370S) [136] Alabi ZO, Durosinmi MA. Legg-Calve-Perthes’ disease associated with chronic myeloid
Gaucher mutation among patients with Legg-Calve-Perthes disease. Blood Cells Mol Dis leukaemia in a child: case report. East Afr Med J 1989;66:556–9.
2003;31:72–4. [137] Pettersson H, Wingstrand H, Thambert C, Nilsson IM, Jonsson K. Legg-Calvé-Perthes
[104] Koo KH, Song HR, Ha YC, Kim JR, Kim SJ, Kim KI, et al. Role of thrombotic and disease in hemophilia: incidence and etiologic considerations. J Pediatr Orthop
fibrinolytic disorders in the etiology of Perthes’ disease. Clin Orthop Relat Res 1990;10:28–32.
2002;399:162–7. [138] Czeizel A, Lowry RB. Syndrome of cataract, mild microcephaly, mental retardation and
[105] Dilley A, Hooper WC, Austin H, Jamil M, Miller C, Stokes M, et al. The beta fibrinogen gene Perthes-like changes in sibs. Acta Paediatr Hung 1990;30:343–9.
G-455-A polymorphism is a risk factor for Legg-Perthes disease. J Thromb Haemost [139] Ikegawa S, Nagano A, Nakamura K. A case of multiple epiphyseal dysplasia complicated
2003;1:2317–21. by unilateral Perthes’ disease. Acta Orthop Scand 1991;62:606–8.
[106] O’Sullivan M, O’Rourke SK, MacAuley P. Legg-Calvé-Perthes disease in a family: genetic [140] Roy DR. Perthes’-like changes caused by acquired hypothyroidism. Orthopedics
or environmental. Clin Orthop Relat Res 1985;199:179–81. 1991;14:901–4.
[107] Perry DC, Bruce CE, Pope D, Dangerfield P, Platt MJ, Hall AJ. Legg-Calvé-Perthes disease in [141] Hotokebuchi T, Miyahara H, Sugioka Y. Legg-Calvé-Perthes’ disease in the Russell-Silver
the UK: geographic and temporal trends in incidence reflecting differences in degree of syndrome. A report of two cases and a review of the literature. Int Orthop 1994;18:32–7.
deprivation in childhood. Arthritis Rheum 2012;64:1673–9. [142] Livesey JP, Hay SM, Bell MJ. Perthes disease affecting three female first-degree relatives.
[108] Perry DC, Bruce CE, Pope D, Dangerfield P, Platt MJ, Hall AJ. Comorbidities in Perthes’ J Pediatr Orthop B 1998;7:230–1.
disease: a case control study using the General Practice Research database. J Bone Joint [143] Levin C, Zalman L, Shalev S, Mader R, Koren A. Legg-Calvé-Perthes disease, protein
Surg Br 2012;94:1684–9. C deficiency, and beta-thalassemia major: report of two cases. J Pediatr Orthop 2000;
[109] Miyamoto Y, Matsuda T, Kitoh H, Haga N, Ohashi H, Nishimura G, et al. A recurrent 20:129–31.
mutation in type II collagen gene causes Legg-Calvé-Perthes disease in a Japanese [144] Alkuraya FS. Arthrogryposis, perthes disease, and upward gaze palsy: a novel
family. Hum Genet 2007;121:625–9. autosomal recessive syndromic form of arthrogryposis. Am J Med Genet A 2011;
[110] Li N, Yu J, Cao X, Wu QY, Li WW, Li TF, et al. A novel p. Gly630Ser mutation of COL2A1 in a 155A:297–300.
Chinese family with presentations of Legg-Calvé-Perthes disease or avascular necrosis of [145] Adapala NS, Kim HK. Comprehensive genome-wide transcriptomic analysis of immature
the femoral head. PLoS One 2014;9:e100505. articular cartilage following ischemic osteonecrosis of the femoral head in piglets. PLoS
[111] Kannu P, Irving M, Aftimos S, Savarirayan R. Two novel COL2A1 mutations associated One 2016;11:e0153174.
with a Legg-Calvé-Perthes disease-like presentation. Clin Orthop Relat Res 2011;469: [146] Zhou ZC, Gu SZ, Wu J, Liang QW. VEGF, eNOS, and ABCB1 genetic polymorphisms
1785–90. may increase the risk of osteonecrosis of the femoral head. Genet Mol Res 2015;14:
[112] Zheng L, Wang W, Ni J, Li Z, Xiao T. The association of eNOS gene polymorphism with 13688–98.
avascular necrosis of femoral head. PLoS One 2014;9:e87583. [147] Hong JM, Kim TH, Kim HJ, Park EK, Yang EK, Kim SY. Genetic association of angiogenesis-
[113] Su P, Zhang L, Peng Y, Liang A, Du K, Huang D. A histological and ultrastructural and hypoxia-related gene polymorphisms with osteonecrosis of the femoral head. Exp
study of femoral head cartilage in a new type II collagenopathy. Int Orthop 2010; Mol Med 2010;42:376–85.
34:1333–9. [148] Hong GJ, Lin N, Chen LL, Chen XB, He W. Association between vascular endothelial
[114] Starr-Moss AN, Nowend KL, Alling KM, Zepp EJ, Murphy KE. Exclusion of COL2A1 in growth factor gene polymorphisms and the risk of osteonecrosis of the femoral head:
canine Legg-Calvé-Perthes disease. Anim Genet 2012;43:112–3. systematic review. Biomed Rep 2016;4:92–6.
[115] Guerado E, Garcés G. Perthes’ disease. A study of constitutional aspects in adulthood. [149] Liu Y, Jiang W, Liu S, Su X, Zhou S. Combined effect of tnf-α polymorphisms and
J Bone Joint Surg Br 2001;83:569–71. hypoxia on steroid-induced osteonecrosis of femoral head. Int J Clin Exp Pathol
[116] Purry NA. The Incidence of Perthes’ Disease in three populations groups in the eastern 2015;8:3215–9.
cape region of South Africa. J Bone Joint Surg Br 1982;64:286–8. [150] Li Z, Zhao D, Wang B. ABCB1 gene polymorphisms and glucocorticoid-induced avascular
[117] Metcalfe D, Van Dijck S, Parsons N, Christensen K, Perry DC. A Twin Study of Perthes necrosis of the femoral head susceptibility: a meta-analysis. Med Sci Monit
disease. Pediatrics 2016;137:e20153542. 2014;20:2811–6.
[118] Srzentić S, Spasovski V, Spasovski D, Zivković Z, Matanović D, Bascarević Z, et al. [151] Zhang Y, Kong X, Wang R, Li S, Niu Y, Zhu L, et al. Genetic association of the P-glycoprotein
Association of gene variants in TLR4 and IL-6 genes with Perthes disease. Srp Arh Celok gene ABCB1 polymorphisms with the risk for steroid-induced osteonecrosis of the
Lek 2014;142:450–6. femoral head in Chinese population. Mol Biol Rep 2014;41:3135–46.
S26 Guerado and Caso / Injury, Int. J. Care Injured 47S6 (2016) S16–S26
[152] Xue Y, Zhao ZQ, Hong D, Zhang HJ, Chen HX, Fan SW. MDR1 gene polymorphisms are [154] Gagala J, Buraczynska M, Mazurkiewicz T, Ksiazek A. Endothelial nitric oxide synthase
associated with glucocorticoid-induced avascular necrosis of the femoral head in a gene intron 4 polymorphism in non-traumatic osteonecrosis of the femoral head. Int
Chinese population. Genet Test Mol Biomarkers 2014;18:196–201. Orthop 2013;37:1381–5.
[153] Cui Y, Kaisaierjiang A, Cao P, Wu ZY, Lv Q. Association of apolipoprotein A5 genetic [155] Liang XN, Xie L, Cheng JW, Tan Z, Yao J, Liu Q, et al. Association between PAI-1 4G/5G
polymorphisms with steroid-induced osteonecrosis of femoral head in a Chinese Han Polymorphisms and osteonecrosis of femoral head: a meta-analysis. Thromb Res
population. Diagn Pathol 2014;9:229. 2013;132:158–63.